Sherry Martin
About
Sherry Martin is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics.
According to data from OpenAlex, Sherry Martin has authored 21 papers receiving a total of 679 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Surgery and 4 papers in Genetics. Recurrent topics in Sherry Martin's work include Diabetes Management and Research (16 papers), Diabetes Treatment and Management (13 papers) and Pancreatic function and diabetes (6 papers). Sherry Martin is often cited by papers focused on Diabetes Management and Research (16 papers), Diabetes Treatment and Management (13 papers) and Pancreatic function and diabetes (6 papers). Sherry Martin collaborates with scholars based in United States, Netherlands and United Kingdom. Sherry Martin's co-authors include Honghua Jiang, Jessie L. Fahrbach, Bruce H. R. Wolffenbuttel, William H. Herman, John B. Buse, Jamie Scism‐Bacon, Andrew Ahmann, Julio Rosenstock, Kathleen Dungan and Zvonko Miličević and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Diabetic Medicine.
In The Last Decade
Sherry Martin
19 papers receiving 656 citations
Peers
Sherry Martin
Niall Furlong United Kingdom
F. Storms United Kingdom
Chunshen Pan United States
Randi Grøn Denmark
Silvia Pieralice Italy
Saud Alsifri Saudi Arabia
I. M�hlhauser Germany
Jesús Moreno-Fernández Spain
Robyn K. Pollom United States
M. Hoffman United States
Citations per year, relative to Sherry Martin Sherry Martin (= 1×)
peers
Niall Furlong
Countries citing papers authored by Sherry Martin
Since
Specialization
Citations
This map shows the geographic impact of Sherry Martin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sherry Martin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sherry Martin more than expected).
Fields of papers citing papers by Sherry Martin
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Sherry Martin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sherry Martin. The network helps show where Sherry Martin may publish in the future.
Co-authorship network of co-authors of Sherry Martin
This figure shows the co-authorship network connecting the top 25 collaborators of Sherry Martin. A scholar is included among the top collaborators of Sherry Martin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sherry Martin. Sherry Martin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Martin, Angela, Alan M Batt, Sherry Martin, et al.. (2025). Towards a person-centred holistic consultation framework for paramedics attending non-acute presentations: A multidisciplinary commentary. Edith Cowan University Research Online (Edith Cowan University). 23(1). 46–57.
2.
Patterson, Jan E., et al.. (2022). The Clinical Safety and Effectiveness Course: Ten Years of Experiential Training in Quality Improvement for Practicing Professionals.. PubMed. 37(3). 227–235.
3.
Patterson, Jan E., et al.. (2021). The Clinical Safety and Effectiveness Course: Ten Years of Experiential Training in Quality Improvement for Practicing Professionals. American Journal of Medical Quality. 37(3). 227–235.
4.
Geier, Silke, Michael Lehrke, Sherry Martin, et al.. (2020). PDB60 Drug Treatment Of Type 2 Diabetes Mellitus Patients With An Incident Cardiovascular Comorbidity: An Analysis Based On A Large German Claims Dataset. Value in Health. 23. S516–S516.
5.
Gunasekaran, Karthik, Ramya Iyyadurai, John Antony Jude Prakash, et al.. (2018). Clinical Spectrum, Susceptibility Profile, Treatment and Outcome of Culture-Confirmed Brucellosis from South India. Indian Journal of Medical Microbiology. 36(2). 289–292.
6.
Pozzilli, Paolo, Richard David Leslie, Anne L. Peters, et al.. (2018). Dulaglutide treatment results in effective glycaemic control in latent autoimmune diabetes in adults (LADA): A post‐hoc analysis of the AWARD‐2, ‐4 and ‐5 Trials. Diabetes Obesity and Metabolism. 20(6). 1490–1498.
7.
Matza, Louis S., et al.. (2016). Physician perceptions of GLP-1 receptor agonists in the UK. Current Medical Research and Opinion. 32(5). 857–864.
8.
Jendle, Johan, Marcia A. Testa, Sherry Martin, Honghua Jiang, & Zvonko Miličević. (2016). Continuous glucose monitoring in patients with type 2 diabetes treated with glucagon‐like peptide‐1 receptor agonist dulaglutide in combination with prandial insulin lispro: an AWARD ‐4 substudy. Diabetes Obesity and Metabolism. 18(10). 999–1005.
9.
Arakaki, Richard F., Thomas Blevins, Jonathan K. Wise, et al.. (2013). Comparison of insulin lispro protamine suspension versus insulin glargine once daily added to oral antihyperglycaemic medications and exenatide in type 2 diabetes: a prospective randomized open‐label trial. Diabetes Obesity and Metabolism. 16(6). 510–518.
10.
Jendle, Johan, Sherry Martin, & Zvonko Miličević. (2012). Insulin and GLP-1 analog combinations in type 2 diabetes mellitus: a critical review. Expert Opinion on Investigational Drugs. 21(10). 1463–1474.
11.
Lee, Lauren J., Matthew F Emons, Sherry Martin, et al.. (2012). Association of blood glucose levels with in-hospital mortality and 30-day readmission in patients undergoing invasive cardiovascular surgery. Current Medical Research and Opinion. 28(10). 1657–1665.
12.
Buse, John B., Bruce H. R. Wolffenbuttel, William H. Herman, et al.. (2011). The DURAbility of Basal versus Lispro mix 75/25 insulin Efficacy (DURABLE) Trial. Diabetes Care. 34(2). 249–255.
13.
Lee, Lauren J., Jessie L. Fahrbach, Lauren Nelson, et al.. (2010). Effects of insulin initiation on patient-reported outcomes in patients with type 2 diabetes: Results from the DURABLE trial. Diabetes Research and Clinical Practice. 89(2). 157–166.
14.
Wolffenbuttel, Bruce H. R., et al.. (2009). Initiating insulin therapy in elderly patients with Type 2 diabetes: efficacy and safety of lispro mix 25 vs. basal insulin combined with oral glucose‐lowering agents. Diabetic Medicine. 26(11). 1147–1155.
15.
Buse, John B., Bruce H. R. Wolffenbuttel, William H. Herman, et al.. (2009). DURAbility of Basal Versus Lispro Mix 75/25 Insulin Efficacy (DURABLE) Trial 24-Week Results. Diabetes Care. 32(6). 1007–1013.
16.
Herman, William H., Kathleen Dungan, Bruce H. R. Wolffenbuttel, et al.. (2009). Racial and Ethnic Differences in Mean Plasma Glucose, Hemoglobin A1c, and 1,5-Anhydroglucitol in Over 2000 Patients with Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism. 94(5). 1689–1694.
17.
Engel-Nitz, Nicole, Sherry Martin, Peter P. Sun, Don P. Buesching, & Vivian Fonseca. (2008). Cardiovascular events and insulin therapy: A retrospective cohort analysis. Diabetes Research and Clinical Practice. 81(1). 97–104.
18.
Fahrbach, Jessie L., Scott J. Jacober, Honghua Jiang, & Sherry Martin. (2008). The DURABLE Trial Study Design: Comparing the Safety, Efficacy, and Durability of Insulin Glargine to Insulin Lispro Mix 75/25 Added to Oral Antihyperglycemic Agents in Patients with Type 2 Diabetes. Journal of Diabetes Science and Technology. 2(5). 831–838.
19.
Wolffenbuttel, Bruce H. R., John B. Buse, William H. Herman, et al.. (2008). The DURABLE trial 24-week results : Safety and efficacy of insulin lispro mix 25 vs. insulin glargine added to oral antihyperglycaemic agents (OHAs) in patients with type 2 diabetes (T2D). Data Archiving and Networked Services (DANS). 51.
20.
Rosenstock, Julio, et al.. (2007). Advancing Insulin Therapy in Type 2 Diabetes Previously Treated With Glargine Plus Oral Agents. Diabetes Care. 31(1). 20–25.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Niall Furlong Breakdown of academic impact, for papers by F. Storms Breakdown of academic impact, for papers by Chunshen Pan Breakdown of academic impact, for papers by Randi Grøn Breakdown of academic impact, for papers by Silvia Pieralice Breakdown of academic impact, for papers by Saud Alsifri Breakdown of academic impact, for papers by I. M�hlhauser Breakdown of academic impact, for papers by Jesús Moreno-Fernández Breakdown of academic impact, for papers by Robyn K. Pollom Breakdown of academic impact, for papers by M. Hoffman